Blastome pleuropulmonaire (PPB)
Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.
| ID | DIS-PLEUROPULMONARY-BLASTOMA |
|---|---|
| Type | Maladie |
| Alias | Blastome pleuropulmonaire associé à DICER1PPBPBB type I (kystique)PPB de type II (mélangé kystique/solide)PBB Type III (solide)Blastome pleuropulmonaireПлевропульмональна бластома (PPB) |
| État | reviewed 2026-05-20 | pending_clinical_signoff |
| Maladies | Aucune déclaration |
| Sources | SRC-COG SRC-NCCN-PEDIATRIC-SARCOMA |
Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.
| icd_o_3_morphology | 8973/3 |
|---|---|
| icd_o_3_topography | ["C34"] |
| icd_10 | C34 |
| who_classification | WHO Thoracic Tumours 5th ed (2021): Pleuropulmonary blastoma — pediatric embryonal lung-pleural tumour with three morphologic types (I, II, III) representing a continuum of progression from cystic (Type I) → mixed (Type II) → solid (Type III) |
Notes
Pleuropulmonary blastoma is the canonical DICER1-syndrome cancer — PPB diagnosis in any child should trigger DICER1 germline testing AND cascade-testing of parents + siblings. The Type I → Type II → Type III progression model is unique among pediatric cancers in offering a true surveillance-curable precursor lesion (Type I PPB is histologically benign-appearing cystic disease that, if completely resected, has excellent prognosis; if left in situ, may progress to the higher-mortality Type II/III). Treatment by type: Type I — complete surgical resection; close follow-up imaging for new cysts or solid transformation. Type II/III — surgical resection (often combined lobectomy / pneumonectomy with CNS prophylaxis consideration); IVADo (ifosfamide, vincristine, actinomycin-D, doxorubicin) or similar sarcoma-style regimens; CNS-directed therapy for Type III given high CNS-relapse risk. Distinguishing PPB Type I from congenital pulmonary airway malformation (CPAM) — the most common pediatric cystic lung lesion — is the major early-life diagnostic challenge: family history of DICER1-related malignancies + multi-locular or septated cysts argue for PPB over CPAM and should prompt referral to...
Utilisé par
Maladie
DIS-CYSTIC-NEPHROMA- Néphrome kystiqueDIS-PINEOBLASTOMA- PineoblastomeDIS-PITUITARY-BLASTOMA- Blastome pituitaireDIS-SERTOLI-LEYDIG-OVARIAN- Tumeur des cellules Sertoli-Leydig de l'ovaire
Sources
SRC-SCHULTZ-DICER1-2018- DICER1 et conditions connexes : Identification des personnes à risque et recommandations...SRC-STEWART-DICER1-REVIEW-2019- Risque de néoplasme chez les personnes présentant une variante pathogène de la germe chez DICER1